SLS (SLS) Stock Price & Analysis
SLS (SLS) rose 0.00% to USD 11.32 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
SLS last closed at USD 11.32; the session ranged USD 11.22–12.48 on volume of 6,646,973 shares. Market capitalization is —, with a 52-week range of USD 1.39–15.88 (NCM). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 11.32 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 11.32 |
| Open | USD 11.32 |
| Day Range | USD 11.22 – 12.48 |
| 52-Week Range | USD 1.39 – 15.88 |
| Volume | 6,646,973 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SLS)
Nexqual's technical model rates SLS "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 47.47 (neutral) |
| vs SMA50 | Above (USD 10.16) |
| MACD | 0.58 (positive) |
From SLS's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GLSI | Greenwich LifeSciences, Inc. | USD 12.98 | ▼ 2.19% |
| IMMP | Immutep Limited | USD 0.38 | ▼ 1.41% |
| VTVT | vTv Therapeutics Inc. | USD 30.73 | ▼ 2.97% |
| VERU | Veru Inc. | USD 2.25 | ▼ 0.44% |
| XBIO | Xenetic Biosciences, Inc. | USD 2.64 | ▼ 1.12% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.